DK89685A - ALLOPURINOL DERIVATIVES - Google Patents

ALLOPURINOL DERIVATIVES Download PDF

Info

Publication number
DK89685A
DK89685A DK89685A DK89685A DK89685A DK 89685 A DK89685 A DK 89685A DK 89685 A DK89685 A DK 89685A DK 89685 A DK89685 A DK 89685A DK 89685 A DK89685 A DK 89685A
Authority
DK
Denmark
Prior art keywords
group
defined above
general formula
image
phenyl
Prior art date
Application number
DK89685A
Other languages
Danish (da)
Other versions
DK89685D0 (en
DK162051B (en
DK162051C (en
Inventor
Hans Bundgaard
Erik Falch
Original Assignee
Gea As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK3028/83A external-priority patent/DK302883D0/en
Application filed by Gea As filed Critical Gea As
Priority to DK089685A priority Critical patent/DK162051C/en
Publication of DK89685D0 publication Critical patent/DK89685D0/en
Publication of DK89685A publication Critical patent/DK89685A/en
Publication of DK162051B publication Critical patent/DK162051B/en
Application granted granted Critical
Publication of DK162051C publication Critical patent/DK162051C/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compounds of the general formula Ia or Ib <IMAGE> where R1 is a group of the general formula II <IMAGE> where R3 is alkyl; phenyl; phenyl which is substituted by halogen, lower alkyl, hydroxyl, lower alkoxy, acetoxy or phenoxy; phenyl-lower alkyl, where the phenyl group can be substituted by halogen, lower alkyl, hydroxyl, lower alkoxy, acetoxy or phenoxy; or phenyl-lower alkenyl, where the phenyl group can be substituted by halogen, lower alkyl, hydroxyl, lower alkoxy, acetoxy or phenoxy; or R3 is an aromatic 5- or 6-membered heterocyclic ring which contains 1 or 2 hetero atoms selected from the class consisting of nitrogen, oxygen and sulphur; and A is a single bond or a group of the general formula IIa <IMAGE> where the carbon atom is bonded to the nitrogen atom of the original ring system and where R6 and R7 are identical or different and are each hydrogen or have the same meaning as R3, as defined above; or R1 is a group of the general formula III <IMAGE> where R8 and R9 are identical or different and each denote hydrogen or have the same meaning as R3, as defined above; or R8 and R9, together with the adjacent nitrogen atom, form a 5- or 6-membered heterocyclic ring which, over and above the nitrogen atom, can contain one or two additional hetero atoms selected from the class consisting of nitrogen, oxygen and sulphur; Y is a single bond or a group of the general formula IIIa <IMAGE> where n is an integer from 1 to 5; and A, R6 and R7 are as defined above; or R1 is a group of the general formula IV <IMAGE> where A is as defined above, and R3' has the same meaning as R3 defined above, with the proviso that R3' is not ethyl when A is a bond; or R1 is a group of the general formula VI <IMAGE> where R10 is a mono- or poly-halogenated lower alkyl group, and A is as defined above; or R1 is a group of the general formula VII <IMAGE> where n and A are as defined above, and R13 is hydroxyl or a group of the general formula -NR8R9, where R8 and R9 are as defined above; or R1 is a group of the general formula IX <IMAGE> where R6 and R7 are as defined above; R2 is any of the groups of the general formulae II, III, IV, VI and VII as defined above, with the proviso that A is only the group of the general formula IIa as defined above; and R5 is hydrogen or has the same meaning as R2 as defined above, and salts thereof. The compounds of the general formulae Ia and Ib are prodrugs of allopurinol and have, inter alia, a much higher solubility in water and/or a higher lipophilicity than allopurinol, which makes these compounds extremely well-suited for oral, parenteral and rectal administration to a homeothermic animal such as man. Following administration, these compounds will be converted into allopurinol.
DK089685A 1983-06-30 1985-02-27 ALLOPURINOL PRODUCTS DK162051C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK089685A DK162051C (en) 1983-06-30 1985-02-27 ALLOPURINOL PRODUCTS

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DK302883 1983-06-30
DK3028/83A DK302883D0 (en) 1983-06-30 1983-06-30 ALLOPURINOL PRODUCTS
DK8400057 1984-06-19
PCT/DK1984/000057 WO1985000368A1 (en) 1983-06-30 1984-06-19 Allopurinol prodrugs
DK89685 1985-02-27
DK089685A DK162051C (en) 1983-06-30 1985-02-27 ALLOPURINOL PRODUCTS

Publications (4)

Publication Number Publication Date
DK89685D0 DK89685D0 (en) 1985-02-27
DK89685A true DK89685A (en) 1985-02-27
DK162051B DK162051B (en) 1991-09-09
DK162051C DK162051C (en) 1992-02-10

Family

ID=26064865

Family Applications (1)

Application Number Title Priority Date Filing Date
DK089685A DK162051C (en) 1983-06-30 1985-02-27 ALLOPURINOL PRODUCTS

Country Status (1)

Country Link
DK (1) DK162051C (en)

Also Published As

Publication number Publication date
DK89685D0 (en) 1985-02-27
DK162051B (en) 1991-09-09
DK162051C (en) 1992-02-10

Similar Documents

Publication Publication Date Title
ES473074A1 (en) Thienothiazine derivatives, their preparation and compositions containing them.
FI850829L (en) FOER ALLOPURINOL.
SE8104941L (en) imidazole
ES425084A2 (en) Alkyl and cycloalkylthiophenylalkylaminoalkanols, their salts and the preparation thereof
ES405983A1 (en) N-fluoroalkylated phenylethylamine
SE7713846L (en) BENZIMIDAZOLES AND PROCEDURES FOR THEIR PREPARATION
ES8502977A1 (en) Pilocarpine prodrugs.
DK89685A (en) ALLOPURINOL DERIVATIVES
ES476166A1 (en) Imidazoisoquinoline-diones and salts thereof
ES443536A1 (en) Amine salts of phenyl-4-hydroxypyridazines and the preparation and herbicidal compositions thereof
SE7704246L (en) DISINFECTANT
ES345283A1 (en) 2-(2-arylhydrazino)-2-imidazolines
ES8202003A1 (en) Ergoline derivatives, process for their preparation, and pharmaceutical compositions
DK0524512T3 (en) Antihypertensive combination
ES425208A1 (en) Sulphamylbenzoic acids and preparation thereof
FI850969A0 (en) MONOSILYLERADE AMINOFENYLETYLAMINDERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING VID BEFRAEMJANDET AV TILLVAEXT.
SE429864B (en) PROCEDURE FOR PREPARING 1- (3-PHENYL-PROPYL-4-FUROYL PIPERAZINES
FI933468A (en) Tetrahydronaphthalene derivatives, framstaellning av dessa och therapeutisk anvaendning av dessa
SE7706693L (en) METHODS OF PRODUCING HYDRAZINOPYRIDAZINE DERIVATIVES
ES348125A1 (en) 3-((1-cyano-2-lower alkyl)amino)-2-hydroxypropoxyindoles
ES8504772A1 (en) 7-(4-Pyridyl)-1,8-naphthyridine derivatives and their antibacterial compositions
GB1074744A (en) Improvements in or relating to substituted 9,10-dihydro-4h-benzo[4,5]cyclo-hepta[1,2-b]thiophenes
ES360031A1 (en) Procedure for the preparation of 1,2,4-oxadiazoles isomeros. (Machine-translation by Google Translate, not legally binding)
ES451741A2 (en) Naphthyridine derivatives
ES417065A1 (en) N-(triaryl-methyl)-amidines, process for the preparation thereof and compositions containing the same

Legal Events

Date Code Title Description
PBP Patent lapsed